Your Messages Inbox
Your Article Summary
See Latest ArticlesA New Approach to Managing Safety Information in Clinical Trials
PharmExec, 09/23/09
Safety used to be widely seen as a 'sales prevention' tool. Thankfully that has changed recently. But is it still viewed the same way in clinical trials? The Switzerland–based working group Council for International Organisations of Medical Sciences recently produced a paper on this subject, discussing what pharmaceutical companies can do to embrace drug safety in clinical trials. CIOMS says that there is a need to incorporate newer approaches for managing safety information in the clinical trial setting, and to adapt the methods and tools used in post–approval pharmacovigilance to the early and late stages of pre–approval development of medicinal products.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer HealthCare Pharmaceuticals Inc. Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Bayer HealthCare Pharmaceuticals, 12/07/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09
Article Search
Sponsor